Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Cognitive Aids for the Management of Deteriorating Surgical Patients (CAMDS)

18 stycznia 2019 zaktualizowane przez: B Preckel, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Background and Goal of Study: Adherence to best practice management of emergencies improves through the use of cognitive aids. Aim of this study was to develop and validate cognitive aids for management of deteriorating surgical ward patients (CAMDS) in order to improve adherence to best practice and hereby reduce the likelihood of failure to rescue.

Materials and Methods: Fifty surgical teams will be randomly assigned to manage 150 standardised high fidelity simulation cases of deteriorating patients using the CAMDS or not. There are 10 standardised patient scenarios; pneumonia, pneumothorax, bradycardia, cardiac arrest shockable and non-shockable rhythm, bleeding, myocardial infarction, anaphylaxis, sepsis and loss of consciousness. Two independent observers will score the team's performance in adhering to all the management steps. To assess perceived usability of the CAMDS participants will be asked about eight aspects of the CAMDS. These items will be scored on a Likert scale (0= strongly disagree to 4= strongly agree).

Przegląd badań

Status

Zakończony

Interwencja / Leczenie

Szczegółowy opis

INTRODUCTION AND RATIONALE

The suboptimal management of deteriorating surgical patients is an important factor in preventable death and morbidity in hospitals. Several studies have shown that the mortality rate in different hospitals is not associated with different complication rates between these hospitals but with the ability to effectively rescue patients from these complications. This has been called failure to rescue. Misapplication of the early warning score, failure to recognize a deteriorating patient, delays in seeking senior advice and delays in adequate management or inadequate resuscitation are found to be important factors. Strategies focusing on the management of complications once they occur may be essential to improve outcomes.

Recent publications emphasized human factors as a cause that contributed towards failure to rescue. Medical staff often fails to recognize a deteriorating patient. Partly because there is lack of insight in the development of a critically illness. Ludikhuize showed that care-providers mostly rate their care, provided to patients in the hours preceding a life-threatening adverse event, as good. However, independent experts felt that patients often could have been identified as deteriorating, much earlier. It does not, however, seem wholly unexpected that the assessment of a deteriorating patient by an experienced ICU consultant is superior to the assessment made by a ward nurse or junior surgical doctor.

Another important cause of failure to rescue was the failure to react promptly tot a deterioration in care. It has been reported that the Rapid Response Team (RRT) was called in only 30% of cases when criteria for activating the RRT were fulfilled. Sometimes because of an unclear escalation policy, sometimes because of self-doubt and insecurity of the care provider or because of hierarchical barriers.

It is known that the management of intraoperative emergencies improves through the use of cognitive aids.These cognitive aids remind practitioners to best practice management of these emergencies and hereby increase adherence to these practices. Because the CAMDS will assist surgical staff at the bedside in the assessment of deteriorating surgical patients and prompt best practice management of specific complications it is likely that failure to rescue will also decrease. The CAMDS can furthermore prompt a nurse or junior doctor to liaise with seniors and/or critical care staff. Because they can communicate a differential diagnosis and management steps taken so far from the CAMDS this might decrease self-doubt and insecurity in liaising with seniors or critical care staff. A, clear escalation policy on the CAMDS, embraced by the hospital can further assist in the timely escalation of care and breakdown of hierarchical barriers. This will result in a decrease of the likelihood of failure to rescue.

OBJECTIVES

Primary Objective is to answer the following research questions:

Will the correct application of the CAMDS improve adherence (measured by the omission of critical steps) to best practice management of perioperative complications in surgical patients?

Secondary Objective is to validate the CAMDS in terms of user perceived usability.

STUDY DESIGN Randomized study comparing adherence rates to best practice management of patients with a perioperative complication in a high fidelity simulation session with and without the use of the CAMDS.

The investigators will develop and validate cognitive aids for the assessment and management of deteriorating surgical patients (CAMDS). These CAMDS contain instructions for doctors and nursing staff to assess, manage and escalate care of deteriorating surgical patients. These management instructions will be derived from best practices that are linked with improved mortality and morbidity in surgical patients. The cognitive aids will be developed in an expert team of 2 surgical consultants, 2 surgical registrars (one junior and one senior), 3 nurses from a surgical ward, 1 critical care consultant, 2 anaesthetic consultants and an anaesthetic registrar. The content of the CAMDS and accompanying evidence will be determined within this team. The design of the CAMDS will be done by adaptation of the local emergency manual, which is a bundle of cognitive aids for intraoperative emergencies adapted from the Stanford Emergency Manual (with permission). The design for this bundle has been thoroughly tested. The simulation scenarios will be based upon the 10 different conditions that are in the CAMDS. Scenarios will be tested and validated through a pilot study.

STUDY POPULATION Population (base) Surgical doctors from the surgical departments of several Dutch hospitals will be included in the study. Doctors and nurses will be assigned to teams and randomised to a management scenario with the use of the CAMDS or without the use of the CAMDS. They will have to give individual consent to participate in the study and are only allowed to participate in the study once.

Sample size calculation Sample size calculation is based on a cluster-randomized design. No previous data on the effectiveness of CAMDS is available, thus no formal power analysis was possible. Available data on the use of cognitive aids in simulated crisis scenarios in the operating theatre shows a baseline omission of critical steps of about 75%.The investigators therefore estimate that the correct application of the CAMDS will reduce the omission of critical steps with 50%. Each team will run through three scenarios and will randomised to complete the scenario with or without the CAMDS. Across these three scenarios participants will be measured on a total of 45 (15 per scenario) process measures for adherence. Based on this effect size and an estimated intra-cluster correlation coefficient within teams of 0.1 and a mean cluster size of 45, with a two-sided alpha level of 0.05 and 80% power, 25 surgical teams per study arm are needed.

METHODS

Main study parameter/endpoint:

Failure to adhear to best practice (omission of critical management steps) for the given scenarios, as predefined by the team that developed the CAMDS.

Secondary study parameters/endpoints (if applicable):

Perceived utility, ease of use and user satisfaction of the CAMDS. Eight aspects of perceived usability; ease of use, logical order of described management steps, readability of the CAMDS, whether the CAMDS provided overview, interrupted treatment, improved treatment, recommendation to use and suitability for daily use, will be assessed through a survey. These items will be scored on a five-point Likert scale (strongly agree to strongly disagree). Completion of the questionnaires will be voluntary and no compensation of any kind will be provided.

Randomisation, blinding and treatment allocation This is a prospective randomised, non-blinded study. Surgical teams will be randomised through a computer generated code in sealed opaque envelopes to the CAMDS group or non CAMDS group. Randomisation will take place only after the teams have been made familiar with the cognitive aid bundle and the high fidelity simulation laboratory, so during the introduction study staff and participants will be unaware of allocation.

Study procedures Surgical teams will be asked to manage a simulated scenario of a deteriorating surgical patient. The simulated scenario will take place in the high fidelity simulator of the Academic Medical Centre Amsterdam and will be recorded on video. Two independent observers will score the key processes for managing the specific scenarios. Interrater reliability will be assessed with Cohen's Kappa. There are three independent EuSim trained simulation laboratory operators (CHSOS) who will run the simulated patient, the Laerdal SimMan 3G. Ten standardised patient cases- pneumonia, pneumothorax, bradycardia, cardiac arrest shockable and non-shockable rhythm, bleeding, myocardial infarction, anaphylaxis, sepsis and loss of consciousness- were preprogrammed for the study. So a correct action resulted in progression in the scenario.

Withdrawal of individual subjects Not applicable.

Premature termination of the study The study will be terminated after enclosure of the last participating surgical team (n=50)

STATISTICAL ANALYSIS Will be performed using SPSS statistics. All data will be checked for normal distribution using the Kolmogorov-Smirnov test and histograms. For normal distributed, continuous variables, an independent Student´s t-test will be used and the variables will be presented as mean ± standard deviation (SD). A p-value <0.05 will be considered as statistically significant. For categorical variables, cross tabulation and the Pearson chi square test will be applied and variables will be allegorized as number and/or percentage of the total. Not normally distributed data will be compared using the Man-Whitney U-test where appropriate, and data will be presented by the median and the interquartile range. For the primary outcome measure univariate analysis to test failure rates (percentage omitted critical steps). Multivariate analysis will also be done to compare failure rates with and without the CAMDS. Descriptive statistics will be used to describe perceived usability.

No interim analysis will be done

Handling and storage of data and documents Video data from the simulated scenarios will be stored on a password protected folder in a computer drive only available by the investigators. All questionnaires will be anonymously collected and electronic copies of the files will be stored in the same folder as the video data. Participants will be asked to fill in a training grade to allow stratification of the data. The study staff will ensure that the participants' anonymity is maintained. All documents will be stored securely and only accessible by study staff. The trial will comply with the Data Protection Act, which requires data to be anonymised as soon as it is practical to do so.

This study is funded by an Innovation Grant from the Academic Medical Centre, Amsterdam.

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

50

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Noord Holland
      • Amsterdam, Noord Holland, Holandia, 1105 AZ
        • Amsterdam UMC, location: Academic Medical Centre

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dziecko
  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Tak

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • All hospital surgical staff is eligible

Exclusion Criteria:

  • Surgical staff that is unwilling to give consent
  • Staff that already has participated in the study

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: CAMDS bundle
25 surgical teams will manage 10 standardised simulated deteriorating ward patients with the help of a cognitive aid bundle
Cognitive aids for the assessment and management of deteriorating surgical patients (CAMDS). This bundle contains instructions for doctors and nursing staff to assess, manage and escalate care of deteriorating surgical patients. These management instructions will be derived from best practices that are linked with improved mortality and morbidity in surgical patients.
Brak interwencji: No bundle
25 surgical teams will manage 10 standardised simulated deteriorating ward patients without the help of a cognitive aid bundle

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Failure to adhear to best practice (percentage of omitted critical management steps) for the given scenario
Ramy czasowe: start to end of high fidelity simulation session (aprox. 10 min)
Every scenario consisted of 15 predefined critical management steps (for examle cardiac arrest with a shockable rhythm critical steps would be; start basic life support, open the airway, identify shockable rhythm, defibrillate with appropriate amount of Joules etc.) Primary outcome is the failure to adhear to best practice expressed as percentage of omitted predefined critical management steps.
start to end of high fidelity simulation session (aprox. 10 min)

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Perceived usability of the CAMDS
Ramy czasowe: During debrief of high fidelity simulation session (aprox. 30 min)
Eight aspects of perceived usability; ease of use, logical order of described management steps, readability of the CAMDS, whether the CAMDS provided overview, interrupted treatment, improved treatment, recommendation to use and suitability for daily use, will be assessed through a survey. These items will be scored on a five-point Likert scale (strongly agree to strongly disagree).
During debrief of high fidelity simulation session (aprox. 30 min)

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: Benedikt Preckel, M.D. P.h.D., Amsterdam UMC, location AMC

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Publikacje ogólne

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

7 lutego 2017

Zakończenie podstawowe (Rzeczywisty)

18 grudnia 2018

Ukończenie studiów (Rzeczywisty)

18 grudnia 2018

Daty rejestracji na studia

Pierwszy przesłany

14 stycznia 2019

Pierwszy przesłany, który spełnia kryteria kontroli jakości

18 stycznia 2019

Pierwszy wysłany (Rzeczywisty)

23 stycznia 2019

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

23 stycznia 2019

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

18 stycznia 2019

Ostatnia weryfikacja

1 stycznia 2019

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • W16_209

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj